ArticleJournal of translational medicine2013

Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy.

Sheng-Hua Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.